Based on a comprehensive review of the literature, we believe that the following factors are relevant: first, systemic inflammatory status (such as elevated IL-6 and CRP) is not a necessary factor leading to cognitive impairment in patients; other conditions are also required, such as pre-existing brain pathology. The gene discussed is IL6; the disease is Cognitive impairment.